Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.

Ikoma N, Estrella JS, Hofstetter WL, Ajani JA, Fournier KF, Mansfield PF, Skibber JM, Badgwell BD.

J Gastrointest Surg. 2018 Jul 27. doi: 10.1007/s11605-018-3880-0. [Epub ahead of print]

PMID:
30054780
2.

Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.

Vicente D, Ikoma N, Chiang YJ, Fournier K, Tzeng CD, Song S, Mansfield P, Ajani J, Badgwell BD.

Ann Surg Oncol. 2018 Jul 9. doi: 10.1245/s10434-018-6638-8. [Epub ahead of print]

PMID:
29987602
3.

The ypT category does not impact overall survival in node negative gastric cancer.

Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD.

J Surg Oncol. 2018 Jun 27. doi: 10.1002/jso.25081. [Epub ahead of print]

PMID:
29949666
4.

Patient Selection for Cytoreductive Surgery.

Grotz TE, Fournier KF, Mansfield PF.

Surg Oncol Clin N Am. 2018 Jul;27(3):443-462. doi: 10.1016/j.soc.2018.02.012. Review.

PMID:
29935682
5.

Repeat staging laparoscopy for gastric cancer after preoperative therapy.

Thiels CA, Ikoma N, Fournier K, Das P, Blum M, Estrella JS, Minsky BD, Ajani J, Mansfield P, Badgwell BD.

J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25094. [Epub ahead of print]

PMID:
29878364
6.

Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved.

Ikoma N, Estrella JS, Hofstetter W, Das P, Minsky BD, Ajani JA, Fournier KF, Mansfield P, Badgwell BD.

Ann Surg Oncol. 2018 Jul;25(7):2012-2017. doi: 10.1245/s10434-018-6471-0. Epub 2018 May 10.

PMID:
29748883
7.

Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.

Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BD.

Gastric Cancer. 2018 May 5. doi: 10.1007/s10120-018-0832-z. [Epub ahead of print]

PMID:
29730720
8.

Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy.

Ikoma N, Estrella JS, Blum M, Das P, Chen HC, Wang X, Fournier K, Mansfield P, Ajani J, Badgwell BD.

J Gastrointest Surg. 2018 Aug;22(8):1325-1333. doi: 10.1007/s11605-018-3764-3. Epub 2018 Apr 20.

PMID:
29679346
9.

Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.

Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BD.

Cancer. 2018 Mar 1;124(5):998-1007. doi: 10.1002/cncr.31155. Epub 2018 Feb 2.

10.

A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.

Levine EA, Votanopoulos KI, Shen P, Russell G, Fenstermaker J, Mansfield P, Bartlett D, Stewart JH.

J Am Coll Surg. 2018 Apr;226(4):434-443. doi: 10.1016/j.jamcollsurg.2017.12.027. Epub 2018 Jan 10.

11.

Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography.

Ikoma N, Lee JH, Bhutani MS, Ross WA, Weston B, Chiang YJ, Blum MA, Sagebiel T, Devine CE, Matamoros A Jr, Fournier K, Mansfield P, Ajani JA, Badgwell BD.

J Gastrointest Oncol. 2017 Dec;8(6):1009-1017. doi: 10.21037/jgo.2017.04.04.

12.

Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer.

Ikoma N, Das P, Blum M, Estrella JS, Devine CE, Wang X, Fournier K, Mansfield P, Minsky BD, Ajani J, Badgwell BD.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):660-666. doi: 10.1016/j.ijrobp.2017.07.018. Epub 2017 Jul 20.

PMID:
29280460
13.

Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).

Fisher SB, Rafeeq S, Hess K, Grotz TE, Mansfield P, Royal R, Badgwell B, Fleming J, Fournier K, Mann GN.

J Surg Oncol. 2018 Mar;117(4):685-691. doi: 10.1002/jso.24904. Epub 2017 Nov 28.

PMID:
29193085
14.

Comment on: External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix.

Dineen SP, Royal RE, Mansfield PF, Fournier KF.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):627. doi: 10.1245/s10434-017-6218-3. Epub 2017 Nov 9. No abstract available.

PMID:
29124485
15.

Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance.

Elimova E, Slack RS, Chen HC, Planjery V, Shiozaki H, Shimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA.

Oncotarget. 2017 Jul 13;8(46):81430-81440. doi: 10.18632/oncotarget.19226. eCollection 2017 Oct 6.

16.

Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade.

Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF.

World J Gastrointest Oncol. 2017 Sep 15;9(9):354-362. doi: 10.4251/wjgo.v9.i9.354.

17.

Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm.

Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ.

Ann Surg Oncol. 2017 Nov;24(12):3667-3672. doi: 10.1245/s10434-017-6052-7. Epub 2017 Aug 22.

PMID:
28831698
18.

Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer.

Ikoma N, Blum M, Estrella JS, Wang X, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD.

J Gastrointest Surg. 2017 Oct;21(10):1563-1570. doi: 10.1007/s11605-017-3539-2. Epub 2017 Aug 17.

PMID:
28819789
19.

Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.

Badgwell B, Blum M, Das P, Estrella J, Wang X, Ho L, Fournier K, Royal R, Mansfield P, Ajani J.

Ann Surg Oncol. 2017 Oct;24(11):3338-3344. doi: 10.1245/s10434-017-6047-4. Epub 2017 Aug 10.

PMID:
28799004
20.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.

Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF.

Ann Surg Oncol. 2017 Sep;24(9):2646-2654. doi: 10.1245/s10434-017-5938-8. Epub 2017 Jul 10.

PMID:
28695394
21.

Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy.

Ikoma N, Blum M, Estrella JS, Das P, Hofstetter WL, Fournier KF, Mansfield P, Ajani JA, Badgwell BD.

Gastric Cancer. 2018 Jan;21(1):74-83. doi: 10.1007/s10120-017-0743-4. Epub 2017 Jun 22.

PMID:
28643144
22.

Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer.

Badgwell B, Blum M, Das P, Estrella J, Wang X, Fournier K, Royal R, Mansfield P, Ajani J.

Surg Endosc. 2018 Jan;32(1):512. doi: 10.1007/s00464-017-5668-9. Epub 2017 Jun 22.

PMID:
28643069
23.

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery.

Uemura M, Qiao W, Fournier K, Morris J, Mansfield P, Eng C, Royal RE, Wolff RA, Raghav K, Mann GN, Overman MJ.

BMC Cancer. 2017 May 15;17(1):331. doi: 10.1186/s12885-017-3327-0.

24.

Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy.

Ikoma N, Chen HC, Wang X, Blum M, Estrella JS, Fournier K, Mansfield P, Ajani J, Badgwell BD.

Ann Surg Oncol. 2017 Sep;24(9):2679-2687. doi: 10.1245/s10434-017-5838-y. Epub 2017 Mar 22.

PMID:
28332034
25.

Multimodality Treatment of Gastric Lymphoma.

Ikoma N, Badgwell BD, Mansfield PF.

Surg Clin North Am. 2017 Apr;97(2):405-420. doi: 10.1016/j.suc.2016.11.012. Epub 2017 Feb 14. Review.

PMID:
28325194
26.

Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer.

Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD.

Ann Surg Oncol. 2016 Dec;23(13):4332-4337. Epub 2016 Jul 6.

PMID:
27384751
27.

Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer.

Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani J, Badgwell BD.

Ann Surg Oncol. 2017 Apr;24(4):960-965. doi: 10.1245/s10434-016-5645-x. Epub 2016 Oct 24.

PMID:
27778127
28.

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.

Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A Jr, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA.

Ann Surg Oncol. 2017 Aug;24(8):2291-2301. doi: 10.1245/s10434-016-5601-9. Epub 2016 Oct 21.

PMID:
27770339
29.

Survival rates in T1 and T2 gastric cancer: A Western report.

Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD.

J Surg Oncol. 2016 Oct;114(5):602-606. doi: 10.1002/jso.24382. Epub 2016 Jul 20.

PMID:
27439746
30.

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up.

Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R.

Ann Surg Oncol. 2017 Jan;24(1):187-193. doi: 10.1245/s10434-016-5588-2. Epub 2016 Sep 22.

PMID:
27660258
31.

Carers of people affected by cancer and other long-term conditions at end of life: A qualitative study of providing a bespoke package of support in a rural setting.

Nelson D, Mansfield P, Kane R.

Palliat Med. 2017 Feb;31(2):158-161. doi: 10.1177/0269216316648073. Epub 2016 Jul 10.

PMID:
27160699
32.

Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma.

Grotz TE, Mansfield PF, Royal RE, Mann GN, Rafeeq S, Beaty KA, Overman MJ, Fournier KF.

Ann Surg Oncol. 2016 Sep;23(9):2914-9. doi: 10.1245/s10434-016-5209-0. Epub 2016 Mar 30.

PMID:
27027310
33.

Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma.

Badgwell B, Blum M, Elimova E, Estrella J, Chiang YJ, Das P, Mansfield P, Ajani J.

Ann Surg Oncol. 2016 Jun;23(6):1948-55. doi: 10.1245/s10434-016-5112-8. Epub 2016 Feb 11.

PMID:
26868957
34.

Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.

Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA.

J Surg Oncol. 2016 Jan;113(1):29-35. doi: 10.1002/jso.24087. Epub 2015 Nov 25.

PMID:
26603684
35.

Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?

Kneuertz PJ, Hofstetter WL, Chiang YJ, Das P, Blum M, Elimova E, Mansfield P, Ajani J, Badgwell B.

Ann Surg Oncol. 2016 Feb;23(2):626-32. doi: 10.1245/s10434-015-4898-0. Epub 2015 Nov 12.

PMID:
26564243
36.

Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy.

Pujara D, Mansfield P, Ajani J, Blum M, Elimova E, Chiang YJ, Das P, Badgwell B.

J Surg Oncol. 2015 Dec;112(8):883-7. doi: 10.1002/jso.24077. Epub 2015 Oct 19.

37.

Health: The No-Man's-Land Between Physics and Biology.

Mansfield PJ.

J Altern Complement Med. 2015 Oct;21(10):593-7. doi: 10.1089/acm.2014.0334.

PMID:
26447724
38.

Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy.

Day RW, Badgwell BD, Fournier KF, Mansfield PF, Aloia TA.

J Gastrointest Surg. 2016 Jan;20(1):146-53; discussion 153. doi: 10.1007/s11605-015-2949-2. Epub 2015 Sep 28.

PMID:
26416411
39.

Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates.

Dineen SP, Robinson KA, Roland CL, Beaty KA, Rafeeq S, Mansfield PF, Royal RE, Fournier KF.

J Surg Res. 2016 Jan;200(1):158-63. doi: 10.1016/j.jss.2015.08.003. Epub 2015 Aug 13.

PMID:
26342838
40.

Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.

Badgwell B, Ajani J, Blum M, Ho L, Fournier K, Chiang YJ, Matamoros A, Das P, Mansfield P.

Ann Surg Oncol. 2016 Jan;23(1):156-62. doi: 10.1245/s10434-015-4643-8. Epub 2015 Jun 10.

PMID:
26059652
41.

Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis.

Taggart MW, Abraham SC, Overman MJ, Mansfield PF, Rashid A.

Arch Pathol Lab Med. 2015 Jun;139(6):782-90. doi: 10.5858/arpa.2013-0047-OA.

PMID:
26030247
42.

Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.

Badgwell B, Blum M, Estrella J, Chiang YJ, Das P, Matamoros A, Fournier K, Mansfield P, Ajani J.

J Am Coll Surg. 2015 Jul;221(1):83-90. doi: 10.1016/j.jamcollsurg.2015.04.004. Epub 2015 Apr 15.

PMID:
26002780
43.

Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery.

Badgwell B, Roy-Chowdhuri S, Chiang YJ, Matamoros A, Blum M, Fournier K, Mansfield P, Ajani J.

J Surg Oncol. 2015 Jun;111(7):875-81. doi: 10.1002/jso.23907. Epub 2015 Apr 14.

PMID:
25872485
44.

A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.

Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF.

Ann Surg Oncol. 2015 Oct;22(11):3640-6. doi: 10.1245/s10434-015-4446-y. Epub 2015 Feb 20.

45.

Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.

Choe JH, Overman MJ, Fournier KF, Royal RE, Ohinata A, Rafeeq S, Beaty K, Phillips JK, Wolff RA, Mansfield PF, Eng C.

Ann Surg Oncol. 2015 Aug;22(8):2578-84. doi: 10.1245/s10434-014-4335-9. Epub 2015 Jan 13.

PMID:
25582740
46.

Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel.

Brar SS, Mahar AL, Helyer LK, Swallow C, Law C, Paszat L, Seevaratnam R, Cardoso R, McLeod R, Dixon M, Yohanathan L, Lourenco LG, Bocicariu A, Bekaii-Saab T, Chau I, Church N, Coit D, Crane CH, Earle C, Mansfield P, Marcon N, Miner T, Noh SH, Porter G, Posner MC, Prachand V, Sano T, van de Velde C, Wong S, Coburn NG.

JAMA Surg. 2014 Jan;149(1):18-25. doi: 10.1001/jamasurg.2013.3959.

PMID:
24225775
47.

Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas.

Raghav KP, Shetty AV, Kazmi SM, Zhang N, Morris J, Taggart M, Fournier K, Royal R, Mansfield P, Eng C, Wolff RA, Overman MJ.

Oncologist. 2013;18(12):1270-7. doi: 10.1634/theoncologist.2013-0186. Epub 2013 Oct 22.

48.

Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume.

Avritscher EB, Cooksley CD, Rolston KV, Swint JM, Delclos GL, Franzini L, Swisher SG, Walsh GL, Mansfield PF, Elting LS.

Support Care Cancer. 2014 Feb;22(2):527-35. doi: 10.1007/s00520-013-2006-1. Epub 2013 Oct 19.

PMID:
24141699
49.

What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel.

Dixon M, Mahar A, Paszat L, McLeod R, Law C, Swallow C, Helyer L, Seeveratnam R, Cardoso R, Bekaii-Saab T, Chau I, Church N, Coit D, Crane CH, Earle C, Mansfield P, Marcon N, Miner T, Noh SH, Porter G, Posner MC, Prachand V, Sano T, Van de Velde CJ, Wong S, Coburn N.

Surgery. 2013 Nov;154(5):1100-9. doi: 10.1016/j.surg.2013.05.021. Epub 2013 Sep 26.

PMID:
24075275
50.

Giant hepatic hemangioma masquerading as a gastric subepithelial tumor.

Kochar R, Atiq M, Lee JH, Landon G, Mansfield PF, Bhutani MS.

Gastroenterol Hepatol (N Y). 2013 Jun;9(6):396-8. No abstract available.

Supplemental Content

Loading ...
Support Center